CNBC Pro

Jefferies says it’s time to buy these Indian pharmaceutical stocks, sees 20% upside for one

A staff member stands besides a desk stocked with medicines and health monitoring equipments inside the temporarily converted Covid-19 coronavirus care centre at the Commonwealth Games stadium in New Delhi on December 22, 2021.
MONEY SHARMA | AFP via Getty Images

Jefferies said it's time to buy these Indian pharmaceutical stocks, one of which has potential gains of nearly 20%.

More In Street Calls

CNBC ProBlackRock downgrades stocks, citing Fed over-tightening and China risk
CNBC ProMotorola is a defensive growth story that has plenty of upside potential, Morgan Stanley says
CNBC ProCiti downgrades several apparel stocks, including Gap, because of inflation hitting consumers